Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study
2022 ◽
Vol 7
(1)
◽
pp. 100342
J.J. Lin
◽
A. Muzikansky
◽
E. Kennedy
◽
H. Kuberski
◽
L.L. Stober
◽
...
2020 ◽
Vol 25
◽
pp. 61-66
Gerard M. Walls
◽
Jamie B. Oughton
◽
Anthony J. Chalmers
◽
Sarah Brown
◽
Fiona Collinson
◽
...
2016 ◽
Vol 27
◽
pp. ix148
A. Bessho
◽
N. Nogami
◽
T. Kubo
◽
H. Kitajima
◽
S. Ikeo
◽
...
Milada Zemanova
◽
Marketa Cernovska
◽
Libor Havel
◽
Tomas Bartek
◽
Sarka Lukesova
◽
...
2017 ◽
Vol 12
(1)
◽
pp. S905
Satoshi Ikeo
◽
Naoyuki Nogami
◽
Hiromoto Kitajima
◽
Hiroshige Yoshioka
◽
Akihiro Bessho
◽
...
2000 ◽
Vol 29
(1)
◽
pp. 69
◽
T Kurata
◽
T Tamura
◽
N Yamamoto
◽
I Sekine
◽
H Kunitoh
◽
...
2003 ◽
Vol 5
(1)
◽
pp. 40-45
◽
Faye M. Johnson
◽
Jonathan M. Kurie
◽
Beverly O. Peeples
◽
J. Jack Lee
◽
Lei Feng
◽
...
2009 ◽
Vol 75
(3)
◽
pp. S110
◽
J.H. Heinzerling
◽
R.S. Hughes
◽
R. Govindan
◽
J.D. Bradley
◽
J.D. Schiller
◽
...
2013 ◽
Vol 79
◽
pp. S64-S65
D.B. Landau
◽
E. Miles
◽
M. Illsley
◽
V. Laurence
◽
S. Hughes
◽
...
2011 ◽
Vol 69
(3)
◽
pp. 825-834
◽
Jordi Rodon
◽
Charlotte D. Jacobs
◽
Quincy Chu
◽
Eric K. Rowinsky
◽
Arturo Lopez-Anaya
◽
...
2000 ◽
Vol 29
(1)
◽
pp. 112
◽
A.T Skarin
◽
C.M Lynch
◽
J Lucca
◽
A.L Boral
◽
T.J Lynch
◽
...